These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 20014995)
1. Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension. Orme M; Collins S; Dakin H; Kelly S; Loftus J Curr Med Res Opin; 2010 Mar; 26(3):511-28. PubMed ID: 20014995 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Stewart WC; Konstas AG; Nelson LA; Kruft B Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination. Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314 [TBL] [Abstract][Full Text] [Related]
4. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy. Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure. Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials. Aptel F; Cucherat M; Denis P J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension. Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study. Chiseliţă D; Antohi I; Medvichi R; Danielescu C Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674 [TBL] [Abstract][Full Text] [Related]
11. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Li N; Chen XM; Zhou Y; Wei ML; Yao X Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898 [TBL] [Abstract][Full Text] [Related]
12. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension. Olander K; Zimmerman TJ; Downes N; Schoenfelder J; Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478 [TBL] [Abstract][Full Text] [Related]
13. Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma. Holmstrom S; Buchholz P; Walt J; Wickstrøm J; Aagren M Curr Med Res Opin; 2005 Nov; 21(11):1875-83. PubMed ID: 16307709 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure. Shin DH; Feldman RM; Sheu WP; Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375 [TBL] [Abstract][Full Text] [Related]
15. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%. Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191 [TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH Ophthalmology; 2005 Jul; 112(7):1177-85. PubMed ID: 15921747 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension. Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309 [TBL] [Abstract][Full Text] [Related]
19. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma. Yildirim N; Sahin A; Gultekin S J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]